Unraveling the role of interferon-stimulated neutrophils: A promising biomarker for immunotherapy efficacy and prognosis in gastric adenocarcinoma.
Gastric adenocarcinoma
DOI:
10.1200/jco.2025.43.4_suppl.472
Publication Date:
2025-01-27T14:37:03Z
AUTHORS (2)
ABSTRACT
472 Background: Despite significant advancements in immunotherapy, the identification of effective predictive biomarkers for treatment response gastric adenocarcinoma (GAC) remains a critical challenge. Discovering such could enhance patient stratification and improve therapeutic outcomes. Methods: We conducted comprehensive analysis 18 specimens obtained from 10 GAC patients, both prior to following immunotherapy. Utilizing single-cell RNA sequencing, we compared cellular composition functional phenotypes these specimens, with particular emphasis on tumor-infiltrating immune cells previously uncharacterized neutrophil subclusters. Results: Our identified eight distinct subclusters, including Neu01_S100A12, Neu02_VEGF, Neu03_CCL3_CCL4, Neu04_IL1β, Neu05_CXCR4, Neu06_IFN-Stimulated, Neu07_Proliferative, Neu08_B-cell_related. Notably, presence IFN-Stimulated neutrophils was positively correlated efficacy immunotherapy GAC, finding that further validated through analyses public datasets in-house cohort studies employing multiplex immunohistochemistry. Additionally, served as prognostic indicators across multiple datasets. Investigations revealed engage communication other components within tumor microenvironment, CD8+ T cells, macrophages, B thereby promoting pro-inflammatory anti-tumor phenotype. Importantly, pan-cancer demonstrated consistent efficacy-predicting potential various cancer types. Conclusions: represent promising biomarker predicting prognosis GAC. findings offer novel insights into underlying mechanisms highlight avenues personalized strategies management
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....